Northern Gritstone — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
adsilico builds generative AI technology that creates diverse virtual patient populations—digital models of human anatomy, physiology, and pathology—to run in silico trials that assess medical device safety and performance before human testing.
AI & Machine LearningHealthtechMedical Devices
Dr Nishant RavikumarinDr Zeike TaylorinProf Alejandro FrangiSheena Macphersonin
Co-investorsParkwalk Advisors
MicroLub is a UK-based deep-tech ingredient company that develops protein-based biolubricant molecules — protein microgels coated with polysaccharides — that reduce molecular friction to replace fats and oils in food and personal care products while retaining their mouthfeel and texture.
BiotechDeep TechFoodTechLeeds, GB
Anwesha Sarkar(Founder)in
Co-investorsLIFTTPraetura Ventures
Phagenesis develops targeted pharyngeal electrical stimulation technology to treat neurogenic dysphagia by restoring neural pathways for safe swallowing.
Deep TechDigital HealthHealthtechMedical Devices
Co-investorsAphelion CapitalInnvotec Ltd.EQT Life SciencesSectoral Asset Management
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.